---
figid: PMC10375442__etm-26-02-12108-g03
pmcid: PMC10375442
image_filename: etm-26-02-12108-g03.jpg
figure_link: /pmc/articles/PMC10375442/figure/f3-ETM-26-2-12108/
number: Figure 3
figure_title: ''
caption: 'Effect of Sal on the VEGF signaling pathway in vitro. (A) Representative
  western blots of VEGFR-2, p-VEGFR-2, AKT, p-AKT, p38, p-p38 and β-actin. Quantitative
  analysis of the relative levels of (B) p-VEGFR-2, (C) p-AKT and (D) p-p38 normalized
  to those of total VEGFR-2, AKT and p38, respectively. Values are presented as the
  mean ± SD (n=3 per group); *P<0.05, **P<0.01, ***P<0.001 vs. the control group;
  ##P<0.01, &P<0.05, &&P<0.01 as indicated. Sal, salvianolate; VEGF, vascular endothelial
  growth factor; VEGFR-2, VEGF receptor 2; p-, phosphorylated; Control group, untreated
  HUVECs; s-control group, HUVECs treated with supernatant of RAW264.7 cells; Sal
  group, HUVECs treated with 10 µM Sal; s-Sal group, HUVECs treated with supernatant
  of Sal (10 µM)-treated RAW264.7 cells; VEGF group, HUVECs treated with 10 ng/ml
  VEGF as a positive control.'
article_title: Pro‑angiogenic activity of salvianolate and its potential therapeutic
  effect against acute cerebral ischemia.
citation: Jiazhen Xu, et al. Exp Ther Med. 2023 Aug;26(2):409.
year: '2023'

doi: 10.3892/etm.2023.12108
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- salvianolate
- ischemic stroke
- angiogenesis
- macro

---
